[go: up one dir, main page]

SI1820792T1 - Postopek za pripravo adamantanaminov - Google Patents

Postopek za pripravo adamantanaminov

Info

Publication number
SI1820792T1
SI1820792T1 SI200631279T SI200631279T SI1820792T1 SI 1820792 T1 SI1820792 T1 SI 1820792T1 SI 200631279 T SI200631279 T SI 200631279T SI 200631279 T SI200631279 T SI 200631279T SI 1820792 T1 SI1820792 T1 SI 1820792T1
Authority
SI
Slovenia
Prior art keywords
formula
treatment
adamantanamine
disease
methyl
Prior art date
Application number
SI200631279T
Other languages
English (en)
Inventor
Christian Schickaneder
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of SI1820792T1 publication Critical patent/SI1820792T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/06—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/62—Preparation of compounds containing amino groups bound to a carbon skeleton by cleaving carbon-to-nitrogen, sulfur-to-nitrogen, or phosphorus-to-nitrogen bonds, e.g. hydrolysis of amides, N-dealkylation of amines or quaternary ammonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/30—Isothioureas
    • C07C335/32—Isothioureas having sulfur atoms of isothiourea groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI200631279T 2006-02-21 2006-02-21 Postopek za pripravo adamantanaminov SI1820792T1 (sl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06003477A EP1820792B1 (en) 2006-02-21 2006-02-21 Process for the preparation of adamantanamines

Publications (1)

Publication Number Publication Date
SI1820792T1 true SI1820792T1 (sl) 2012-04-30

Family

ID=36754153

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200631279T SI1820792T1 (sl) 2006-02-21 2006-02-21 Postopek za pripravo adamantanaminov

Country Status (13)

Country Link
US (1) US20090082596A1 (sl)
EP (1) EP1820792B1 (sl)
JP (1) JP5235683B2 (sl)
CN (1) CN101389594B (sl)
AT (1) ATE541827T1 (sl)
AU (1) AU2007218140B2 (sl)
CA (1) CA2640127C (sl)
DK (1) DK1820792T3 (sl)
ES (1) ES2379181T3 (sl)
PL (1) PL1820792T3 (sl)
PT (1) PT1820792E (sl)
SI (1) SI1820792T1 (sl)
WO (1) WO2007096124A1 (sl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1908748A1 (en) * 2006-10-05 2008-04-09 Krka Process for the preparation of memantine and its hydrochloric acid salt form
WO2010007351A1 (en) * 2008-07-14 2010-01-21 Cipla Limited Process for the preparation of memantine and its salts and intermediate for use therein
CN101560157B (zh) * 2009-06-02 2013-09-18 王彦明 盐酸金刚烷胺生产工艺及其专用设备
CN102070463A (zh) * 2009-06-11 2011-05-25 辽宁利锋科技开发有限公司 具有金刚烷结构药物美金刚胺及其衍生物和类似物抗肿瘤新适应症的应用
US20120130130A1 (en) * 2009-06-29 2012-05-24 Merz Pharma Gmbh & Co. Kgaa Method of preparing neramexane
ES2416071T3 (es) * 2009-06-29 2013-07-30 Merz Pharma Gmbh & Co. Kgaa Método para preparar 1-amino-1,3,3,5,5-pentametilciclohexano
WO2011000537A1 (en) 2009-06-29 2011-01-06 Merz Pharma Gmbh & Co. Kgaa Method of preparing 1-chloroacetamido-1,3,3,5,5-pentamethylcyclohexane
WO2011000539A1 (en) * 2009-06-29 2011-01-06 Merz Pharma Gmbh & Co. Kgaa Method of preparing neramexane
CN101993377A (zh) * 2009-08-07 2011-03-30 出光兴产株式会社 具有金刚烷骨架的胺类和季铵盐的制造方法
JP6094837B2 (ja) * 2013-01-23 2017-03-15 三菱瓦斯化学株式会社 メマンチンの製造プロセス
CN103483205B (zh) * 2013-10-12 2015-02-04 合肥久诺医药科技有限公司 一种高纯度盐酸美金刚的制备方法
CN103524353B (zh) * 2013-10-12 2015-03-25 合肥久诺医药科技有限公司 一种高纯度盐酸美金刚的制备方法
CN104693039B (zh) * 2015-01-06 2016-11-16 中山大学 一种金刚烷胺类衍生物及其制备方法和应用
CN105399636A (zh) * 2015-12-18 2016-03-16 天津民祥生物医药股份有限公司 一种利用盐酸金刚烷胺制备金刚烷胺游离胺的工艺

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3391142A (en) 1966-02-09 1968-07-02 Lilly Co Eli Adamantyl secondary amines
NL7305644A (sl) * 1972-04-20 1973-10-23
DE2318461A1 (de) 1973-04-12 1974-10-31 Merz & Co Verfahren zur herstellung von 1,3,5trisubstituierten adamanta-verbindungen
SU805609A1 (ru) * 1979-10-12 1981-09-30 Предприятие П/Я В-2343 S-(1-адамантилкарбпмоилметил) изотиуроний хлорид,обладающий антивирусной активностью
ES2059602T3 (es) 1989-04-14 1994-11-16 Merz & Co Gmbh & Co Uso de derivados de adamantano para la prevencion y tratamiento de isquemia cerebral.
US5948820A (en) * 1994-08-22 1999-09-07 Yoshitomi Pharmaceutical Industries, Ltd. Benzene compound and pharmaceutical use thereof
CZ288445B6 (en) 1996-06-20 2001-06-13 Lachema Np Process for preparing hydrochloride of 5-amino-1,3-dimethyltricyclo(3,3,1,1 3,7 )decane
GB0001093D0 (en) 2000-01-19 2000-03-08 F2 Chemicals Ltd Selective nitrogen functionalisation of organic compounds
GB0018272D0 (en) * 2000-07-25 2000-09-13 Vernalis Research Limited Chemical compounds IV
JP4118555B2 (ja) * 2001-12-13 2008-07-16 株式会社トクヤマ Ｎ−（アダマンチル）アミド化合物の製造方法
RU2246482C2 (ru) 2002-12-25 2005-02-20 ООО "Циклан" Способ получения гидрохлорида 1-амино-3,5-диметиладамантана
CN1240668C (zh) 2003-09-10 2006-02-08 上海医药工业研究院 一种新的盐酸美金刚制备方法
WO2005062724A2 (en) * 2003-12-31 2005-07-14 Sun Pharmaceutical Industries Limited Novel process for the preparation of aminoadamantane derivatives
JP2007518755A (ja) * 2004-01-22 2007-07-12 ノイロサーチ アクティーゼルスカブ モノアミン神経伝達物質再取り込み阻害剤及びｎ−メチル−ｄ−アスパラギン酸（ｎｍｄａ）受容体アンタゴニストを含む医薬組成物
US7456224B2 (en) * 2004-04-05 2008-11-25 Forest Laboratories Holdings, Ltd. Method for treating autism
EP1879849A1 (en) * 2005-05-11 2008-01-23 Dr. Reddy's Laboratories, Inc. Process for preparing memantine

Also Published As

Publication number Publication date
WO2007096124A1 (en) 2007-08-30
CN101389594A (zh) 2009-03-18
JP5235683B2 (ja) 2013-07-10
CN101389594B (zh) 2013-06-12
PL1820792T3 (pl) 2012-06-29
AU2007218140B2 (en) 2010-08-19
US20090082596A1 (en) 2009-03-26
CA2640127C (en) 2015-08-11
ATE541827T1 (de) 2012-02-15
EP1820792A1 (en) 2007-08-22
AU2007218140A1 (en) 2007-08-30
JP2009527517A (ja) 2009-07-30
PT1820792E (pt) 2012-04-10
CA2640127A1 (en) 2007-08-30
DK1820792T3 (da) 2012-04-10
EP1820792B1 (en) 2012-01-18
ES2379181T3 (es) 2012-04-23

Similar Documents

Publication Publication Date Title
PT1820792E (pt) Processo para a preparação de adamantanaminas
TW200833682A (en) Pharmaceutical compounds
UA102817C2 (ru) Способ синтеза агомелатина
EP2765130A3 (en) Process for producing pyrrole compound
UA100367C2 (uk) Спосіб одержання мемантину і його гідрохлориду
IL183244A0 (en) Process for the preparation of 1-amino-3,5-dimethyladamantane hydrochloride
EP2298734A3 (en) Cyclobutyl amine derivatives
UA93225C2 (ru) 3'-алкоксиспироциклопентилзамещенные производные тетрамовой кислоты и гербицидное средство ha их ochobe
NZ600119A (en) Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
IL196894A0 (en) Process for preparing 3-dihalomethylpyrazole-4-carboxylic acid derivatives
NZ562235A (en) Benzimidazole and pyridoimidazole derivatives as CRF receptor antagonists, for treating affective disorder, depression, or anxiety
EP1604989A8 (en) DPP-IV inhibitors
TW200833657A (en) Novel process
UA83691C2 (ru) Применение замещенных 2-аминотетралинов для упреждающего лечения болезни паркинсона
MX2009000480A (es) Bencilaminas, un proceso para su produccion y su uso como agentes antiinflamatorios.
TW200714598A (en) Urea derivatives, methods for their manufacture, and uses therefor
TN2010000219A1 (en) 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents
MY148769A (en) Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments
JO2928B1 (en) A method for the preparation of ferroquine with amine by convergent reduction
WO2008081726A1 (ja) アミド又はラクタムの製造法
TW200633977A (en) Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
MX2007013872A (es) Procedimiento para la produccion de 4-bifenililazetidina-2-onas.
BRPI0606659A2 (pt) processos para a preparação de álcoois aminoetoxibenzìlicos
MY179041A (en) Crystalline forms of a 3-carboxypropyl-aminotetralin compound
AU2003290055A1 (en) Improved neutralization of isophorone nitrile synthesis products